An Observational Study of GIOTRIF (Afatinib) for First Line Therapy in Patients With Advanced Non Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR)-Mutations.

09/11/2026
09/11/2026
EU PAS number:
EUPAS1000001175
Study
Finalised
Documents
Study protocol
Updated protocol
English (569.35 KB - PDF) View document
Study results
Study results
English (249.18 KB - PDF) View document
Study report
No information provided.
ENCePP Seal
No information provided.